Abstract
Association of High Body Mass Index with Response Outcomes in Patients with CML-CP Treated with Dasatinib Versus Imatinib in the First Line: Exploratory Post Hoc Analysis of the Phase 3 DASISION Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have